WO2003104261A3 - Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto - Google Patents
Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto Download PDFInfo
- Publication number
- WO2003104261A3 WO2003104261A3 PCT/US2003/018197 US0318197W WO03104261A3 WO 2003104261 A3 WO2003104261 A3 WO 2003104261A3 US 0318197 W US0318197 W US 0318197W WO 03104261 A3 WO03104261 A3 WO 03104261A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pablo
- polypeptide
- bcl
- interacts
- uses related
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003247516A AU2003247516A1 (en) | 2002-06-10 | 2003-06-09 | Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16591002A | 2002-06-10 | 2002-06-10 | |
US10/165,910 | 2002-06-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003104261A2 WO2003104261A2 (en) | 2003-12-18 |
WO2003104261A3 true WO2003104261A3 (en) | 2004-03-25 |
Family
ID=29732096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/018197 WO2003104261A2 (en) | 2002-06-10 | 2003-06-09 | Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003247516A1 (en) |
WO (1) | WO2003104261A2 (en) |
-
2003
- 2003-06-09 WO PCT/US2003/018197 patent/WO2003104261A2/en not_active Application Discontinuation
- 2003-06-09 AU AU2003247516A patent/AU2003247516A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
HUANG D. ET AL.: "The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4", THE EMBO JOURNAL, vol. 17, no. 4, 1998, pages 1029 - 1039, XP002970527 * |
MAC FARLANE M. ET AL.: "Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 39, 27 September 2002 (2002-09-27), pages 36611 - 36616, XP002970526 * |
MEDEK A. ET AL.: "The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands", J. AM. CHEM. SOC., vol. 122, 2000, pages 1241 - 1242, XP002970528 * |
YAMAGUCHI H. ET AL.: "Bcl-XL protects BimEL-induced Bax conformational change and cytochrome c release independent of interacting with Bax or BimEl", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 44, 1 November 2002 (2002-11-01), pages 41604 - 41612, XP002970525 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003104261A2 (en) | 2003-12-18 |
AU2003247516A1 (en) | 2003-12-22 |
AU2003247516A8 (en) | 2003-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1085766A1 (en) | Expression vectors comprising the mcmv ie2 promoter | |
DK1641925T3 (en) | Food additives comprising pseudomonas non-maltogenic exoamylase variants | |
DE60322426D1 (en) | ||
TW200611910A (en) | Interferon-alpha polypeptides and conjugates | |
ATE529442T1 (en) | IMPROVED HUMAN INTERFERON MOLECULES AND THEIR USES | |
EP1824971A4 (en) | Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof | |
DE602005009972D1 (en) | ION SOURCE WITH ESSENTIALLY PLANAR DESIGN | |
ATE462006T1 (en) | ISOFORM OF VEGF | |
YU9404A (en) | Peptide-based multimeric targeted contrast agents | |
ATE373081T1 (en) | CELL LINE | |
DK1608745T3 (en) | FVII or FVIIa variants | |
MX2021008131A (en) | Methods and compositions for the treatment of fabry disease. | |
TW200518669A (en) | Animal model for protease activity and liver damage | |
RS51325B (en) | Polypeptides having antimicrobial activity and polynucleotides encoding same | |
PT1569518E (en) | Synergistic compositions | |
SG165168A1 (en) | New adenoviruses, nucleic acids coding therefor and their use | |
MY143382A (en) | Aqueous rodenticide formulations | |
MX2007007355A (en) | 5-(2,2-dimethyl-cycloprodyl)-3-methyl-pen-2-enenitrile as fragrance and flavour. | |
WO2003104261A3 (en) | Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto | |
SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
MY150196A (en) | Rumc peptides with antimicrobial activity | |
WO2004078939A3 (en) | REGULATION OF Mdm2 FUNCTION | |
PL1945657T3 (en) | Tlr3 glycosylation site muteins and methods of use | |
GB0125773D0 (en) | Constructs | |
EP1373525A4 (en) | Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |